Nutriband Inc (NTRB) Stock Price, Quote & News

Company Profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Industry: Biotechnology

Sector: Healthcare

Phone: 407 377 6695

Website: www.nutriband.com

Address:

121 South Orange Avenue, Suite 1500, Orlando, United States

birdmanCap Aug. 19 at 1:19 AM

$NTRB lol dude it’s up 10 % in a week what are talking about…🤡

1 · Reply

Covode13 Aug. 18 at 6:56 PM

$NTRB this is a bust!! No news from any board members. The dividend in shares was a complete waste.

0 · Reply

Pacificstock27 Aug. 15 at 2:32 PM

$NTRB nice close $3.30 Any good news on updates could possibly trigger nice volume.

0 · Reply

NetworkNewsWire Aug. 13 at 7:02 PM

MissionIRNewsBreaks – $NTRB CEO to Present at 2026 Georgia Life Sciences Summit https://ibn.fm/9RcYB

0 · Reply

nutriband_com Aug. 13 at 3:08 PM

🎤 $NTRB Update Nutriband CEO & Co-Founder Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit on Aug. 26 as part of the CEO Spotlight. The Summit brings together leaders across biotech, medtech, research, manufacturing & investment. 🔗Full release: https://www.nutriband.com/post/nutriband-ceo-gareth-sheridan-to-present-at-the-2026-georgia-life #Nutriband #NTRB #Biotech #LifeSciences #AVERSA

0 · Reply

NNTrader Aug. 13 at 1:49 PM

$NTRB finally some news

0 · Reply

Channelchek Aug. 12 at 2:53 PM

Noble Capital Markets Research Report: Nutriband ($NTRB) – Looking Forward To Product Milestones In The Second Half FY2026 AVERSA Fentanyl Continues To Make Progress. Nutriband has been working in several areas to advance AVERSA Fentanyl toward the market. These include preparations for the registration trial, manufacturing, and commercialization. We continue to see AVERSA Fentanyl as an important product that could make fentanyl a safe, abuse-resistant option for pain relief. Read full report here: https://www.channelchek.com/news-channel/nutriband-ntrb-looking-forward-to-product-milestones-in-the-second-half-fy2026

0 · Reply

birdmanCap Aug. 11 at 3:53 PM

$NTRB 👀

0 · Reply

Pacificstock27 Aug. 10 at 1:50 PM

$NTRB Warrants expiring in less than 2 months. Maybe some news on updates would be nice

0 · Reply

birdmanCap Aug. 9 at 6:59 PM

$NTRB this definitely looks like it bottomed out. I’m adding more Monday if it holds $3

0 · Reply

Market Cap	39.26M
Revenue (ttm)	2.04M
Net Income (ttm)	-8.23M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-403.43%
Debt to Equity Ratio	0.01

Volume	6,300
Avg Vol	10,854
Day's Range	N/A - N/A
Shares Out	12.16M
Stochastic %K	99%
Beta	1.98
Analysts	Strong Sell
Price Target	$15.00